ANDREW CIVITELLO to Aged
This is a "connection" page, showing publications ANDREW CIVITELLO has written about Aged.
Connection Strength
0.309
-
Incidental diagnosis of interrupted aortic arch in a 72-year-old man. Tex Heart Inst J. 2009; 36(5):494-5.
Score: 0.023
-
Use of a percutaneous ventricular assist device for treatment of cardiogenic shock due to critical aortic stenosis. Tex Heart Inst J. 2006; 33(4):487-9.
Score: 0.019
-
Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. 2024 Sep; 10(9):2049-2058.
Score: 0.017
-
Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
Score: 0.016
-
Continuous-Flow Left Ventricular Assist Device Support in Patients with Ischemic Versus Nonischemic Cardiomyopathy. Tex Heart Inst J. 2021 Sep 01; 48(4).
Score: 0.014
-
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial. Circulation. 2021 04 27; 143(17):1673-1686.
Score: 0.013
-
Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients. ASAIO J. 2020 05; 66(5):539-546.
Score: 0.013
-
Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival. ASAIO J. 2020 03; 66(3):283-290.
Score: 0.013
-
Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
Score: 0.012
-
Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020 01 01; 30(1):47-53.
Score: 0.012
-
Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. Ann Thorac Surg. 2019 04; 107(4):1132-1138.
Score: 0.011
-
A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial). J Card Fail. 2018 Oct; 24(10):661-671.
Score: 0.011
-
Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation. J Card Surg. 2018 Aug; 33(8):469-478.
Score: 0.011
-
Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2018 08; 106(2):513-519.
Score: 0.011
-
Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support. Artif Organs. 2018 Jun; 42(6):589-596.
Score: 0.011
-
Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices. J Artif Organs. 2018 Jun; 21(2):180-187.
Score: 0.011
-
Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle. Ann Thorac Surg. 2018 03; 105(3):799-806.
Score: 0.011
-
Incidence, Predictors, and Significance of?Ventricular Arrhythmias in Patients With?Continuous-Flow Left Ventricular Assist Devices: A 15-Year Institutional Experience. JACC Clin Electrophysiol. 2018 02; 4(2):257-264.
Score: 0.011
-
Left ventricular outflow tract closure during LVAD implantation: 2 cases of patients supported for over 6?years. J Artif Organs. 2017 Dec; 20(4):350-353.
Score: 0.011
-
Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017 Jan; 48(1):27-34.
Score: 0.010
-
Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):267-75, 278.e1.
Score: 0.009
-
Trauma in patients with continuous-flow left ventricular assist devices. Am J Cardiol. 2013 Nov 01; 112(9):1520-2.
Score: 0.008
-
Percutaneous ventricular assist device in hypertrophic obstructive cardiomyopathy with cardiogenic shock: bridge to myectomy. Ann Thorac Surg. 2012 Mar; 93(3):978-80.
Score: 0.007
-
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009 Feb; 2(2):91-6.
Score: 0.006
-
Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
Score: 0.005
-
Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2006 Mar; 18(3):93-6.
Score: 0.005
-
Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006; 33(2):111-5.
Score: 0.005
-
Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery. Tex Heart Inst J. 2004; 31(1):84-6.
Score: 0.004